Financial Analysis: Lichen China (NASDAQ:LICN) and Astrana Health (NASDAQ:ASTH)

Lichen China (NASDAQ:LICN) and Astrana Health (NASDAQ:ASTH) are both finance companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, earnings, institutional ownership, valuation, risk, analyst recommendations and dividends.

Analyst Ratings

This is a summary of current recommendations and price targets for Lichen China and Astrana Health, as provided by MarketBeat.com.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Lichen China	0	0	0	0	N/A
Astrana Health	0	0	4	1	3.20

Astrana Health has a consensus target price of $59.00, suggesting a potential upside of 7.06%. Given Astrana Health’s higher probable upside, analysts plainly believe Astrana Health is more favorable than Lichen China.

Insider & Institutional Ownership

52.8% of Astrana Health shares are owned by institutional investors. 8.5% of Astrana Health shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Risk & Volatility

Lichen China has a beta of -2.68, suggesting that its share price is 368% less volatile than the S&P 500. Comparatively, Astrana Health has a beta of 1.2, suggesting that its share price is 20% more volatile than the S&P 500.

Profitability

This table compares Lichen China and Astrana Health’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Lichen China	N/A	N/A	N/A
Astrana Health	4.30%	10.71%	6.10%

Earnings & Valuation

This table compares Lichen China and Astrana Health”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Lichen China	$39.76 million	1.29	$8.34 million	N/A	N/A
Astrana Health	$1.59 billion	1.94	$60.72 million	$1.32	41.75

Astrana Health has higher revenue and earnings than Lichen China.

Summary

Astrana Health beats Lichen China on 12 of the 12 factors compared between the two stocks.

About Lichen China

Lichen China Limited, together with its subsidiaries, operates as an investment holding company, provides financial and taxation, education support, and software and maintenance services in the People's Republic of China and internationally. The company offers financial and taxation related management consultation, internal control management consultation, annual or regular consultation, and internal training and general consultation services; and education support services, including marketing, operational, and technical support, as well as sells teaching and learning materials. It also provides Lichen Education Accounting Practice System V1.0, a financial and taxation training software, and academic affairs management system to partnered institutions under the partnership agreements, as well as offers software installation, training, and after sales technical and maintenance support services. Lichen China Limited was founded in 2004 and is based in Jinjiang, China.

About Astrana Health

Astrana Health, Inc., Inc., a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients. It offers care coordination services to patients, families, primary care physicians, specialists, acute care hospitals, alternative sites of inpatient care, physician groups, and health plans. The company's physician network consists of primary care physicians, specialist physicians and extenders, and hospitalists. It serves patients, primarily covered by private or public insurance, such as Medicare, Medicaid, and health maintenance organization plans; and non-insured patients. The company was formerly known as Apollo Medical Holdings, Inc. and changed its name to Astrana Health, Inc. in February 2024. Astrana Health, Inc. was incorporated in 1985 and is headquartered in Alhambra, California.